DEAL ANNOUNCEMENT / PRESS RELEASE
March 19, 2026
Read time: 3 min
McDermott Will & Schulte advised Owkin on the carve-out of Waiv (formerly Owkin Dx) and its $33 million financing.
Waiv builds AI solutions in digital pathology to advance precision oncology.
The Series A financing was led by Alpha Intelligence Capital Fund II, OTB Fund 2, Karista, Serena Data Ventures II and SISTAFUND.
McDermott Will & Schulte advised Owkin, alongside Owkin’s in-house legal team that comprised Pierre-Henri Brieau, Anne-Charlotte Paut and Sarah Candelibes- with:
- Emmanuelle Trombe, partner, Sophie Lafay and Lucie Martin, counsel, Natacha Vasak and Camille Pasquereau, associates, on Life Sciences and Corporate aspects
- Romain Desmonts, partner and Fanny Le Pogam, associate, on tax aspects
Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.
